Readability of informed consent forms, sponsor participation in industry trials, and conflict of interest disclosure.
Informed consent is a crucial feature of clinical research trials. Guidelines on developing an informed consent form urge writers to use standard plain language to provide patients with all of the relevant information they need on risks and benefits in order for them to make well-considered decisions about their treatment.
There has been a lot of concern about bias and influence in industry-sponsored studies following a number of articles suggesting that industry-sponsored trials usually favour the company's product.
Off-label use is the practice of prescribing a drug for an unapproved indication or age group or using an unapproved dosage or route of administration. It is illegal for pharmaceutical companies to directly promote off-label uses, but many companies have paid physicians and researchers to endorse off-label uses of their products
You must be a member of EMWA in order to download the full article.
EMWA members please log in to download the full article.
If you would like to become a member of EMWA, please join here.
Deputy Managing Editor
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
In the Bookstores
Medical Communications/Writing for Patients
My First Medical Writing
News from the EMA
Out on Our Own
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Lay out Designer